These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 37812119)

  • 1. Social Value, Beneficial Information, and Obligations to Participants in a Trial of Novel COVID-19 Vaccines.
    Earl J; Dawson L
    Am J Bioeth; 2023 Oct; 23(10):126-128. PubMed ID: 37812119
    [No Abstract]   [Full Text] [Related]  

  • 2. Researcher Obligations to Participants in Novel COVID-19 Vaccine Research.
    Wilfond BS; Duenas DM; Johnson LM
    Am J Bioeth; 2023 Oct; 23(10):119-120. PubMed ID: 37812093
    [No Abstract]   [Full Text] [Related]  

  • 3. Ensure Palestinians have access to COVID-19 vaccines.
    Martin S; Arawi T
    Lancet; 2021 Feb; 397(10276):791-792. PubMed ID: 33577758
    [No Abstract]   [Full Text] [Related]  

  • 4. Ancillary Care Obligations of Clinical Trial Investigators in the COVID-19 Pandemic.
    Babu TM; Wald A
    Am J Bioeth; 2023 Oct; 23(10):123-125. PubMed ID: 37812103
    [No Abstract]   [Full Text] [Related]  

  • 5. Co-Development of a Web Application (COVID-19 Social Site) for Long-Term Care Workers ("Something for Us"): User-Centered Design and Participatory Research Study.
    Saunders CH; Sierpe A; Stevens G; Elwyn G; Cantrell M; Engel J; Gonzalez M; Hayward M; Huebner J; Johnson L; Jimenez A; Little NR; McKenna C; Onteeru M; Oo Khine M; Pogue J; Salinas Vargas JL; Schmidt P; Thomeer R; ; Durand MA
    J Med Internet Res; 2022 Sep; 24(9):e38359. PubMed ID: 35926074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensational media reporting is common when describing COVID-19 therapies, detection methods, and vaccines.
    Ottwell R; Puckett M; Rogers T; Nicks S; Vassar M
    J Investig Med; 2021 Aug; 69(6):1256-1257. PubMed ID: 34021053
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial.
    Al Kaabi N; Zhang Y; Xia S; Yang Y; Al Qahtani MM; Abdulrazzaq N; Al Nusair M; Hassany M; Jawad JS; Abdalla J; Hussein SE; Al Mazrouei SK; Al Karam M; Li X; Yang X; Wang W; Lai B; Chen W; Huang S; Wang Q; Yang T; Liu Y; Ma R; Hussain ZM; Khan T; Saifuddin Fasihuddin M; You W; Xie Z; Zhao Y; Jiang Z; Zhao G; Zhang Y; Mahmoud S; ElTantawy I; Xiao P; Koshy A; Zaher WA; Wang H; Duan K; Pan A; Yang X
    JAMA; 2021 Jul; 326(1):35-45. PubMed ID: 34037666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equitable and Effective Distribution of the COVID-19 Vaccines - A Scientific and Moral Obligation.
    Binagwaho A; Mathewos K; Davis S
    Int J Health Policy Manag; 2022 Feb; 11(2):100-102. PubMed ID: 33949818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Misrepresentation about vaccines that are scaring women.
    Moodley J; Khaliq OP; Mkhize PZ
    Afr J Prim Health Care Fam Med; 2021 Jun; 13(1):e1-e2. PubMed ID: 34212737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-affirmation increases acceptance of information on COVID-19 vaccines and promotes vaccination intention.
    Li S; Xia Y; Zhao W; Miao X; Xu Q
    J Behav Med; 2023 Apr; 46(1-2):303-310. PubMed ID: 35133549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trial participants' rights after authorisation of COVID-19 vaccines.
    Dal-Ré R; Orenstein W; Caplan AL
    Lancet Respir Med; 2021 Apr; 9(4):e30-e31. PubMed ID: 33476582
    [No Abstract]   [Full Text] [Related]  

  • 12. The Need for Novel Approaches in Assessing the Value of COVID-19 Vaccines.
    Angelis A; Baltussen R; Tervonen T
    Am J Public Health; 2021 Feb; 111(2):205-208. PubMed ID: 33439703
    [No Abstract]   [Full Text] [Related]  

  • 13. COVID-19 Vaccines and Professional Obligations for Otolaryngologists.
    Hogikyan ND; Shuman AG
    Otolaryngol Head Neck Surg; 2022 Jul; 167(1):1-2. PubMed ID: 35290137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "First Do No Harm": Effective Communication About COVID-19 Vaccines.
    Broniatowski DA; Dredze M; Ayers JW
    Am J Public Health; 2021 Jun; 111(6):1055-1057. PubMed ID: 33950727
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of a short, animated story-based video on COVID-19 vaccine hesitancy: A study protocol for an online randomized controlled trial.
    Barteit S; Hachaturyan V; Beleites F; Kühn T; Favaretti C; Adam M; Bärnighausen T
    Front Public Health; 2022; 10():939227. PubMed ID: 36081470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergency use of COVID-19 vaccines recommended by the World Health Organization (WHO) as of June 2021.
    Cui X; Wang P; Wei Z
    Drug Discov Ther; 2021 Sep; 15(4):222-224. PubMed ID: 34275974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 vaccines: A perspective from social pharmacology.
    Montastruc JL; Lafaurie M; de Canecaude C; Montastruc F; Bagheri H; Durrieu G; Sommet A
    Therapie; 2021; 76(4):311-315. PubMed ID: 34119317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of information sources on COVID-19 vaccine hesitancy and resistance in sub-Saharan Africa.
    Osuagwu UL; Mashige KP; Ovenseri-Ogbomo G; Envuladu EA; Abu EK; Miner CA; Timothy CG; Ekpenyong BN; Langsi R; Amiebenomo OM; Oloruntoba R; Goson PC; Charwe DD; Ishaya T; Agho KE
    BMC Public Health; 2023 Jan; 23(1):38. PubMed ID: 36609264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examining Facebook Community Reaction to a COVID-19 Vaccine Trial on the Navajo Nation.
    Calac AJ; Bardier C; Cai M; Mackey TK
    Am J Public Health; 2021 Aug; 111(8):1428-1430. PubMed ID: 34464193
    [No Abstract]   [Full Text] [Related]  

  • 20. The Conditional Marketing Authorisation of Covid-19 Vaccines: A Critical Assessment under EU Law.
    Donati A
    Eur J Health Law; 2022 Mar; 29(1):33-52. PubMed ID: 35303726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.